首页> 外文期刊>Radiation oncology >Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis
【24h】

Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis

机译:妇科恶性肿瘤患者调强放疗和三维适形放疗的剂量学比较:系统评价和荟萃分析

获取原文
           

摘要

Background To quantitatively evaluate the safety and related-toxicities of intensity modulated radiotherapy (IMRT) dose–volume histograms (DVHs), as compared to the conventional three-dimensional conformal radiotherapy (3D-CRT), in gynecologic malignancy patients by systematic review of the related publications and meta-analysis. Methods Relevant articles were retrieved from the PubMed, Embase, and Cochrane Library databases up to August 2011. Two independent reviewers assessed the included studies and extracted data. Pooled average percent irradiated volumes of adjacent non-cancerous tissues were calculated and compared between IMRT and 3D-CRT for a range of common radiation doses (5-45Gy). Results In total, 13 articles comprised of 222 IMRT-treated and 233 3D-CRT-treated patients were included. For rectum receiving doses ≥30 Gy, the IMRT pooled average irradiated volumes were less than those from 3D-CRT by 26.40% (30 Gy, p?=?0.004), 27.00% (35 Gy, p?=?0.040), 37.30% (40 Gy, p?=?0.006), and 39.50% (45 Gy, p?=?0.002). Reduction in irradiated small bowel was also observed for IMRT-delivered 40 Gy and 45 Gy (by 17.80% (p?=?0.043) and 17.30% (p?=?0.012), respectively), as compared with 3D-CRT. However, there were no significant differences in the IMRT and 3D-CRT pooled average percent volumes of irradiated small bowel or rectum from lower doses, or in the bladder or bone marrow from any of the doses. IMRT-treated patients did not experience more severe acute or chronic toxicities than 3D-CRT-treated patients. Conclusions IMRT-delivered high radiation dose produced significantly less average percent volumes of irradiated rectum and small bowel than 3D-CRT, but did not differentially affect the average percent volumes in the bladder and bone marrow.
机译:背景技术为了定量评估调强放疗(IMRT)剂量体积直方图(DVHs)与常规3D立体放疗(3D-CRT)相比在妇科恶性肿瘤中的安全性和相关毒性,通过系统回顾相关出版物和荟萃分析。方法截止2011年8月,从PubMed,Embase和Cochrane图书馆数据库中检索相关文章。两名独立审稿人评估了纳入的研究并提取了数据。计算并计算了一系列常规放射剂量(5-45Gy)时,在IMRT和3D-CRT之间对相邻非癌组织的合并平均辐照体积百分比进行了比较。结果总共包括13篇文章,包括222例IMRT治疗和233例3D-CRT治疗的患者。对于直肠接受剂量≥30 Gy的患者,IMRT合并平均照射量比3D-CRT少26.40%(30 Gy,p?=?0.004),27.00%(35 Gy,p?=?0.040),37.30 %(40 Gy,p = 0.006)和39.50%(45 Gy,p = 0.002)。与3D-CRT相比,IMRT递送的40 Gy和45 Gy也观察到辐照小肠的减少(分别降低了17.80%(p?=?0.043)和17.30%(p?=?0.012))。但是,IMRT和3D-CRT合并的低剂量辐照小肠或直肠平均体积百分比,或任何剂量的膀胱或骨髓,均无显着差异。 IMRT治疗的患者没有比3D-CRT治疗的患者更严重的急性或慢性毒性。结论与3D-CRT相比,IMRT提供的高辐射剂量产生的直肠和小肠平均体积百分比明显降低,但对膀胱和骨髓的平均体积百分比没有差异。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号